 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PSID and BICX Up 17% and 11% Respectively on Strong News Today |
|
 Hot Stock to Watch |
Company: PositiveID Corporation (OTCQB: PSID)
|
Last:
Price: 0.0283
Change (%): + 0.0043 (17.92)
Volume: 10,152,833 |
 |
PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes
Providing PCR Results in Minutes Instead of Hours Could Revolutionize the 27 Billion Dollar Global PCR Market
DELRAY BEACH, Fla., March 12, 2015 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company“) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it has successfully completed its first round of testing of its phase II Firefly Dx prototype handheld real-time PCR (polymerase chain reaction) pathogen detection system, and has delivered positive PCR results within 20 minutes. The Company’s Firefly Dx testing was performed at standard laboratory volumes and achieved equivalent results to laboratory-based PCR instruments, which can take hours to perform the same PCR process.
The Company previously announced it completed its Firefly Dx PCR design, and it has now completed successful testing on its Phase II breadboard Firefly Dx system, with consistent and repeated detection of each positive challenge. With the completion of the PCR chip design with confirmatory results, the Company is now in the next phase of testing to encompass optimization and a broader spectrum of tests.
Continue Reading
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
Last:
Price: 0.085
Change (%): + 0.0085 (11.11)
Volume: 110,378 |
 |
BioCorRx, Inc. Enters into Supply Agreement to Distribute Start Fresh Program(r) through Established Wellness Center in Corona, CA
Los Angeles, March 12, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the program will soon be offered in an existing wellness center in Corona, CA through a recently executed supply and distribution agreement with Corona Physical Medicine (CPM). This new relationship is a result of the company's recent letter of intent with Myriad Medical Marketing (MMM) to begin a pilot program for the Start Fresh Program within existing wellness centers. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon a successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide. "It's great to finally be growing our footprint in Southern California and we are looking forward to getting this pilot started here. We believe that the implementation of the program into an existing wellness center with an established patient base will help spread program awareness and help those battling addiction in the Inland Empire area of Southern California," stated COO & interim CEO, Brady Granier.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
